|
|
|
市場調査レポート
頸動脈ステントの世界市場
Carotid Stents
|
Abstract
This report analyzes the worldwide markets for Carotid Stents in Thousand
Units and US$ Million. The report provides separate comprehensive analytics
for the US, Europe and Rest of World. Annual forecasts are provided for each
region for the period of 2004 through 2012. The report profiles 10 companies
including many key and niche players worldwide such as Abbott Vascular, Boston
Scientific Corporation, ev3, Inc., Johnson & Johnson, Cordis Corporation,
Kensey Nash Corporation, and Medtronic, Inc. Market data and analytics are
derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Carotid Stents
II. EXECUTIVE SUMMARY
1. Global Market Overview and Analysis
- Carotid Stents - A Nascent Market
- Current and Future Analysis
- US - Picking Pace
2. Market Dynamics
- Factors Driving Carotid Stents Market
- Clinical Trials & Regulatory Approvals to Accelerate Adoption
- Broader Application of CAS
- Benefiting From Less-Invasive Nature of Procedure
- Acceptance by Various Medical Specialties
- Market Challenges
- Absence of Sufficient Clinical Data
- Surgeons Wary of High-Risk CAS Procedures
- Reimbursement Coverage Issue Hurdles Widespread Adoption
- Fighting for CAS Domain
- Training and Certification of Surgeons - A Major Hurdle
- Stenting Procedure for Transient Ischemic Attacks - A Continuing Dilemma
3. Competitive Scenario
- Table 1: Worldwide Carotid Stents Market (2006-2007E): Market Share of
Leading Players by Revenues for Boston Scientific, Abbott Vascular/Guidant,
Johnson & Johnson/Cordis, Medtronic and Others (includes corresponding
Graph/Chart)
4. Product Overview
- Carotid Stents - An Introduction
- How is Carotid Stenting Helpful?
- Carotid Stents - A Viable Alternative to Surgical Procedures
- Carotid Stenting Lowers Depression Symptoms!!!
- Embolic Protection Devices
- Filter-Based EPD Systems
- Balloon Occlusion Devices
- Basic Carotid Stents Products
- Stent Design
- Carotid Stents of Major Companies Available in the Market
- Carotid Stents Under Development
- Diagnosis of Carotid Artery Blockage
- Eligibility Criteria for Carotid Stenting Procedure
- Potential Candidates for Carotid Stenting
- Patients with High Surgical Risk
- Non-Candidates for Carotid Stenting
- Risk Factors Associated with Carotid Stenting Procedures
- Carotid Artery Stenting (CAS) - The Procedure
- Catheter Insertion Via Femoral Artery
- Advantages of the Procedure
- Post-Stenting Complications
5. Overview of Cardiac Diseases
- Cerebrovascular Disease
- Carotid Artery Disease
- Major Symptoms
- Carotid Artery Stenosis
- Atherosclerosis
- Treatment Procedures for Carotid Artery Disease
- Carotid Endarterectomy (CEA)
- Drawbacks of CEA Procedure
- Carotid Artery Stenting (CAS)
- CAS Versus CEA
- Table 2: Worldwide Carotid Interventions (2006-2008E)): Percentage
Breakdown of Number of Procedures for Carotid Endarterectomy and Carotid
Stenting (includes corresponding Graph/Chart)
- Comparative Study of CAS and CEA Devices
- Benefits of CAS over CEA
- Drawbacks for CAS Penetration
- Risks Associated with CEA and CAS
6. Major Clinical Trials/Studies
- Clinical Trials - Key to Higher Adoption of Carotid Stents
- Major Clinical Trials & Stent Devices Used
- Guidant’s CAPTURE Study
- CAPTURE Study Results Hold Promise for Asymptomatic Patients
- Boston Scientific’s BEACH Trial
- Abbott’s ACT I Trial
- CREST Clinical Trial
- J&J’s SAPPHIRE Clinical Trial
- SAPPHIRE Study Proves Effectiveness of CAS in High-Risk Patients
- Other Trials
- Medtronic’s MAVErIC Trials Validate the Efficiency of Exponent
Carotid Stent
- University of Massachusetts Conduct CAS Efficacy Study in Elderly Patients
- CaRESS Study
7. Product Launches/Approvals
- KNC Obtains Expanded CE Mark Clearance for TriActiv® ProGuard™
- FDA Approves Protege® RX Carotid Stent from ev3
- Abbott Introduces Emboshield® PRO Embolic Protection System in Europe
- Cordis Gains FDA Approval for PRECISE® & ANGIOGUARD® Devices
- Medtronic Obtains CE Mark Approval for Exponent® RX Carotid Stent
- FDA Approves Boston Scientific’s FilterWire EZ™ Embolic
Protection System
- Abbott' s Xact® Carotid Stent Receives FDA Approval
- EndoTex’s NexStent™ Receives CE Mark Approval
- KNC Seeks FDA Approval for TriActiv LFX Trial
- Guidant' s RX ACCULINK™ Carotid Stent System Gets FDA Clearance
- ev3’s Protege GPS Receives CE Mark Approval
- Medtronic’s Interceptor® PLUS Carotid Filter System Receives CE
Mark Approval
- Guidant Unveils RX Accunet Embolic Protection System in European Market
- Guidant Rolls Out ACCULINK™ Carotid Stent System for European Market
8. Recent Industry Activity
- Boston Scientific Acquires EndoTex
- Boston Scientific and Guidant Merge Operations; Abbott Acquires
Guidant’s Vascular Business
- Lumen Commences EPIC Feasibility Study
- Boston Scientific Exclusively Distributes EndoTex’s NexStent™
Carotid Stent
9. Focus on Select Players
- Abbott Vascular (USA)
- Boston Scientific Corporation (USA)
- ev3, Inc. (USA)
- Johnson & Johnson (USA)
- Cordis Corporation (USA)
- Kensey Nash Corporation (USA)
- Medtronic, Inc. (USA)
10. Global Market Perspective
- Table 3: World Recent Past, Current & Future Analysis for Carotid
Stents by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Number of Carotid Stent Procedures in
Thousands for Years 2004 through 2012 (includes corresponding Graph/Chart)
- Table 4: World 9-Year Perspective for Carotid Stents by Geographic Region
- Percentage Breakdown by Number of Carotid Stent Procedures for US, Europe
and Rest of World Markets for Years 2004, 2007 & 2012 (includes
corresponding Graph/Chart)
- Table 5: World Recent Past, Current & Future Analysis for Carotid
Stents by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Revenues in US$ Million for Years 2004
through 2012 (includes corresponding Graph/Chart)
- Table 6: World 9-Year Perspective for Carotid Stents by Geographic Region
- Percentage Breakdown by Annual Revenues for US, Europe and Rest of World
Markets for Years 2004, 2007 & 2012 (includes corresponding Graph/Chart)
III. MARKET
1. The United States
- A. Market Analysis
- Overview
- Current and Future Analysis
- Factors Affecting Growth
- Reimbursement Scenario for CAS
- Restricted Reimbursement Coverage Limits CASPenetration…
- CMS Proposes Expanded Reimbursement Coveragefor Carotid Stenting
- Absence of Regulatory Approvals - A MajorChallenge
- Clinical Trials - Key to Higher Adoption ofCarotid Stents
- Latent Demand
- Key Statistics
- Major Carotid Stents & EPDs in the Market
- US Carotid Stents Market - A Gradual Growth
- Table 7: Carotid Interventions in the US (2006-2008): Percentage
Breakdown of Number of Procedures by Carotid Endarterectomy and Carotid
Stenting (includes corresponding Graph/Chart)
- Trends and Issues
- Convenience in Deployment & Use - Critical forHigher Adoption
- Rapid Exchange Capabilities Facilitate EffectiveControl Over Procedures
- Carotid Stents Assume the Role of MemoryBoosters
- Competitive Landscape
- Table 8: US Carotid Stents Market (2006-2007): Market Share of Leading
Players by Revenues for Boston Scientific, Guidant, Cordis/J&J,
Medtronic and Others (includes corresponding Graph/Chart)
- Product Launches/Approvals
- Strategic Corporate Developments
- Focus on Select Players
- Abbott Vascular
- Boston Scientific Corporation
- ev3, Inc.
- Johnson & Johnson
- Cordis Corporation
- Kensey Nash Corporation
- Medtronic, Inc.
- B. Market Analysis
- Table 9: US Recent Past, Current & Future Analysis for Carotid
Stents Market Independently Analyzed with Annual Number of Carotid Stent
Procedures in Thousands for Years 2004 through 2012 (includes corresponding
Graph/Chart)
- Table 10: US Recent Past, Current & Future Analysis for Carotid
Stents Market Independently Analyzed with Annual Revenues in US$ Million for
Years 2004 through 2012 (includes corresponding Graph/Chart)
2. Europe
- A. Market Analysis
- Current and Future Analysis
- European Carotid Stents Market - An Overview
- ELOCAS Study
- CEA Versus CAS
- Table 11: European Vascular Interventions Market (2004-2006E):
Percentage Breakdown by Number of Procedures for Carotid Artery Stenting and
Carotid Endarterectomy (includes corresponding Graph/Chart)
- Product Launches/Approvals
- Strategic Corporate Development
- B. Market Analytics
- Table 12: European Recent Past, Current & Future Analysis for
Carotid Stents Market Independently Analyzed with Annual Number of Carotid
Stent Procedures in Thousands for Years 2004 through 2012 (includes
corresponding Graph/Chart)
- Table 13: European Recent Past, Current & Future Analysis for
Carotid Stents Market Independently Analyzed with Annual Revenues in US$
Million for Years 2004 through 2012 (includes corresponding Graph/Chart)
3. Rest of World
- A. Market Analysis
- Current and Future Analysis
- Carotid Stenting Scenario in India
- B. Market Analytics
- Table 14: Rest of World Recent Past, Current & Future Analysis for
Carotid Stents Market Independently Analyzed with Annual Number of Carotid
Stent Procedures in Thousands for Years 2004 through 2012 (includes
corresponding Graph/Chart)
- Table 15: Rest of World Recent Past, Current & Future Analysis for
Carotid Stents Market Independently Analyzed with Annual Revenues in US$
Million for Years 2004 through 2012 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
|
 |
